Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 751, pseudogene (RN7SL751P)** is a member of the large family of 7SL RNA pseudogenes present in the human genome. 7SL RNA is best known as the RNA component of the signal recognition particle (SRP), an essential ribonucleoprotein complex that mediates the targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotes[4][5]. However, *RN7SL751P* is a **pseudogene**, which means it is a nonfunctional, often truncated or mutated, genomic copy of the original 7SL RNA gene and is not transcribed into a functional RNA[5]. The vast majority of 7SL pseudogenes, including RN7SL751P, are derived from the reverse transcription and reintegration of 7SL RNA sequences into the genome, but they **do not encode functional RNA or protein and have no known biological function or disease association**[5]. Therefore, *RN7SL751P is not considered a therapeutic target* of any sort, and there are no known drugs or disease mechanisms linked to its sequence. Key notes: - This "target" is a nonfunctional pseudogene, not a receptor, enzyme, or known functional molecule[5]. - There is no evidence or scientific consensus for any biological function, disease association, or therapeutic potential for RN7SL751P. - The locus is properly referred to as a "7SL RNA pseudogene." It should not be considered an actionable molecular target. - If your interest is in the functional 7SL RNA or the signal recognition particle RNA (SRP RNA), clarify with those canonical names instead[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 751, pseudogene (RN7SL751P).